Historical research on reduction of childhood mortality due to vaccination To what extent has the National Vaccination Programme contributed to the prevention of disease and mortality since the beginning of the 20th century?
Need for adjustment authorisation for gene drive applications The National Institute for Public Health and the Environment (RIVM) advises to bring all gene drive applications under the authorisation requirement of the Dutch GMO legislation.
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.
Release of QMRAspot v2 for quantitative microbial risk assessment of drinking water RIVM has developed a new version of QMRAspot (2.0), a user-friendly computational tool to calculate the risk of becoming infected by pathogenic microorganisms in drinking water.
Annoyance and health effects due to European transportation noise At least 20 million adults in Europe are annoyed by transportation noise in agglomerations, from motorways, airports or railways.
Statistical Program to Assess Dietary Exposure now available The Statistical Program to Assess Dietary Exposure (SPADE), developed by RIVM, is now available.
Antibiotic resistance no longer increasing but vigilance remains necessary After continuing to rise for many years, in 2013 the prevalence of resistance to antibiotics levelled out somewhat in both hospitals and primary care.
Need for reliable data on ammonia emissions Many countries in Europe and Central Asia have a need for reliable data on ammonia emissions. These data include ammonia emissions inventories and monitoring of abatement measures.
RIVM forecasting study: a healthier Netherlands with more people living with a chronic disease Dutch people are reaching an increasingly advanced age: in 2030, the life expectancy of men will be 82 years, and of women, 85.